Cargando…
Targeting Advanced Glycation End Products in Cardiac Surgery: The Unexplored Alternative
Autores principales: | Nenna, Antonio, Nappi, Francesco, Chello, Massimo, Spadaccio, Cristiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756255/ https://www.ncbi.nlm.nih.gov/pubmed/26949696 http://dx.doi.org/10.5812/cardiovascmed.31707 |
Ejemplares similares
-
Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease
por: Nenna, Antonio, et al.
Publicado: (2015) -
Heart rate variability: a new tool to predict complications in adult cardiac surgery
por: Nenna, Antonio, et al.
Publicado: (2017) -
Sharing of decision-making for infective endocarditis surgery: a narrative review of clinical and ethical implications
por: Pollari, Francesco, et al.
Publicado: (2020) -
Preoperative aspirin continuation versus replacement therapy with low molecular weight heparin before coronary surgery: effects on postoperative bleeding risk
por: Spadaccio, Cristiano, et al.
Publicado: (2015) -
Guidelines on prosthetic heart valve management in infective endocarditis: a narrative review comparing American Heart Association/American College of Cardiology and European Society of Cardiology guidelines
por: Satriano, Umberto Maria, et al.
Publicado: (2020)